How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

As part of their prize, many of the RSC’s prize winners deliver lectures across the UK and Ireland. These lectures provide an opportunity for winners to share their outstanding work, and in turn, for ...

ACS Interactions brings programs and sessions on innovation, skill development, and scientific discussions. This diverse program features curated scientific discussions, thought-provoking leadership ...

Mark Carney, former Governor of the Bank of England, argues that changing attitudes to value and the marketplace have contributed to a trio of crises: credit, Covid and climate. Why have financial ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recent insider activity for Recursion Pharmaceuticals Inc consisted of 1 transaction totaling $18,400.36. The transaction was a Tax Payment by Ben R Taylor, the company’s Chief Financial Officer.